Delphi Ventures is a venture capital firm that has focused on early stage investing in medical devices and biotechnology for over two decades. With over $850 million in committed capital, Delphi Ventures has funded more than 150 companies. More then 90 of our portfolio companies have either completed an initial public offering been acquired by a major medical corporation.
The partners at Delphi Ventures help build healthcare companies. We provide capital, contacts and leadership to help entrepreneurs realize their vision. Healthcare is our sole focus. Founded in 1988, Delphi was among the first venture capital firms in the United States to focus on early stage medical device and biotechnology investments.
